How is Alzheimer’s disease diagnosed in a person with Down syndrome?
Alzheimer’s disease is a progressive neurological condition. It is a type of dementia. Alzheimer’s disease is characterized by microscopic changes
January 8, 2022
Alzheimer’s disease is a progressive neurological condition. It is a type of dementia. Alzheimer’s disease is characterized by microscopic changes
Dr. Marcia Ratner & Dr. James Hendrix discuss recent developments in Alzheimer’s research. Source: Dr. Marcia Ratner and Dr. James
“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as they were not included among
In June of 2021, the FDA approved a new drug, Aduhelm, from the company Biogen for the treatment of mild
The NTG brought together a national panel of expert researchers and practitioners in the field of Down syndrome and Alzheimer’s
Today, individuals with Down syndrome enjoy a longer life expectancy and are now able to live into their sixties. Unfortunately,
In June, the FDA granted “accelerated approval” to Biogen’s Aduhelm drug. This is the first new drug approved for Alzheimer’s
This document contains the slides from a webinar on aging and Alzheimer’s disease in presented by Drs. Brian Chicoine and
August 18, 2021 LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The National Task Group on Intellectual
LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The National Task Group on Intellectual Disabilities and Dementia